Cancer Treatment Innovations, Leading-Edge Care

The Duke Division of Medical Oncology applies our world-renowned research and treatment innovations to the delivery of leading-edge and compassionate care for individuals with cancer.

Division faculty contribute to basic, translational, and clinical research that is leading to such innovations as:

  • Better understanding of the mechanisms of action of cancer drugs, leading to development of smarter medical therapies
  • Screening tools that identify cancer early in individuals at high risk for breast cancer
  • Evidence-based solutions to improving quality of life for people with cancer and their families
  • Advances in the use of targeted therapies, such as aromatase inhibitors, either alone or in combination with chemotherapies

Basic Research

Division researchers study the mechanism of action of cancer drugs to develop smarter therapies.

Clinical Research

Research efforts include evaluation of novel screening tools to track response to preventive therapy in women at high risk for breast cancer.

Collaborate with Us

Collaborative research is a benchmark of our research program.